Vendor, New York, NY, part of Astorg Group S.à R.L.
Hra Pharma America, Inc.
UEI H6XSBWAVM9G3, CAGE 84RP8
2 awards and $0 obligated between September 25, 2024 and May 26, 2026, 100% under full and open competition, against 500.0 offers on average where reported.
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 2 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 36E79725A0018June 9, 2025, Full and Open Competition, 1 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | BPA for Lysodren and Metopirone with a Period of Performance from 6/10/2025 to 6/9/2026 with Hra Pharma America, INC.NAICS 325412, PSC 6505 | $0 |
| 36F79719D0127September 25, 2024, Full and Open Competition, 999 offers | Nac Federal Supply ScheduleDepartment of Veterans Affairs | FSSNAICS 325412, PSC 6505 | $0 |
- Product and service codes
- 6505 Drugs and Biologicals
- Transactions
- 15 across 2 awards